Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Stomach Neoplasms 7Colorectal Neoplasms 5Rectal Neoplasms 4Colonic Neoplasms 3Neoplasm Metastasis 2Gastrointestinal Neoplasms 2Recurrence 1Rcctal Cancer 1Neoplasms 1Metastatic HER2 Positive Gastroesophageal Junction Cancer 1HER2-positive Locally Advanced Resectable Gastric Cancer 1Gastrointestinal Diseases 1Gastric Adenocarcinoma 1Digestive System Diseases 1Carcinoma 1Adenocarcinoma 1Adebrelimab (SHR-1316) 1

Interventions

Fluorouracil 7Oxaliplatin 6Leucovorin 5Capecitabine 4Blood Specimen Collection 4Bevacizumab 4Pafolacianine 3Irinotecan 3Cisplatin 3Cetuximab 3pembrolizumab 2atezolizumab 2XELOX 2Surveys and Questionnaires 2Standard of Care 2Specimen Handling 2Paclitaxel 2IDRX-42 2Gemcitabine 2Folfox protocol 2Endoscopic Mucosal Resection 2Drug Therapy 2Docetaxel 2Carboplatin 2130-nm albumin-bound paclitaxel 2trastuzumab deruxtecan 1sodium thiosulfate 1sodium propionate 1sacituzumab govitecan 1s-formylglutathione hydrolase 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Gastrointestinal Neoplasms × XELOX × Clear all
NCT06475352 2026-04-23

FUDOSE

UNICANCER

Phase 2 Recruiting
400 enrolled
Gastrointestinal

Gastrointestinal Neoplasms, Neoplasm Metastasis, Neoplasms, Recurrence, Colorectal Neoplasms

NCT05494060 2023-11-07

EXPLORING

The First Affiliated Hospital with Nanjing Medical University

Phase 2 Recruiting
80 enrolled
Gastrointestinal

Carcinoma, Digestive System Diseases, Gastrointestinal Diseases, Gastrointestinal Neoplasms, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡